Israel Englander X Biotech Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in X Biotech Inc. stock. As of the latest transaction made, Millennium Management LLC holds 281,019 shares of XBIT stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

281,019

Previous 361,661 22.3%

Holding current value

$1.93 Million

Previous $1.86 Million 16.9%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.55 - $7.95 $447,563 - $641,103	-80,642 Reduced 22.3%	281,019 $2.17 Million
Q2 2024 Aug 14, 2024	SELL	$4.54 - $9.89 $2.57 Million - $5.59 Million	-565,707 Reduced 61.0%	361,661 $1.86 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $8.13 $530,517 - $1.07 Million	131,642 Added 16.54%	927,368 $7.54 Million
Q4 2023 Feb 14, 2024	SELL	$3.56 - $4.65 $583,953 - $762,748	-164,032 Reduced 17.09%	795,726 $3.18 Million
Q2 2023 Aug 14, 2023	BUY	$3.06 - $6.38 $2.8 Million - $5.83 Million	914,107 Added 2002.38%	959,758 $5.7 Million
Q1 2023 May 15, 2023	SELL	$3.22 - $4.72 $21,229 - $31,118	-6,593 Reduced 12.62%	45,651 $157,000
Q4 2022 Feb 14, 2023	SELL	$3.03 - $3.79 $259,801 - $324,965	-85,743 Reduced 62.14%	52,244 $183,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $525,157 - $862,548	-146,692 Reduced 51.53%	137,987 $500,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $1.37 Million - $2.47 Million	267,953 Added 1602.01%	284,679 $1.6 Million
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $17,893 - $24,251	-2,071 Reduced 11.02%	16,726 $145,000
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $41,467 - $60,857	3,787 Added 25.23%	18,797 $209,000
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $194,379 - $273,782	15,010 New	15,010 $194,000
Q2 2021 Aug 16, 2021	SELL	$15.83 - $17.84 $159,186 - $179,399	-10,056 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.92 - $20.3 $160,091 - $204,136	10,056 New	10,056 $173,000
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $312,188 - $482,855	-30,047 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.89 - $24.94 $964,653 - $2.71 Million	-108,510 Reduced 78.31%	30,047 $319,000
Q4 2019 Feb 14, 2020	BUY	$8.33 - $19.95 $1.02 Million - $2.43 Million	121,895 Added 731.57%	138,557 $2.59 Million
Q3 2019 Nov 14, 2019	BUY	$6.86 - $10.46 $35,301 - $53,827	5,146 Added 44.69%	16,662 $174,000
Q2 2019 Aug 15, 2019	SELL	$6.99 - $11.27 $12,127 - $19,553	-1,735 Reduced 13.09%	11,516 $87,000
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $1.39 Million - $2.24 Million	-199,097 Reduced 93.76%	13,251 $205,000
Q1 2019 May 14, 2019	BUY	$5.05 - $11.62 $824,725 - $1.9 Million	163,312 Added 333.05%	212,348 $2.34 Million
Q4 2018 Feb 14, 2019	SELL	$3.22 - $6.27 $365,122 - $710,967	-113,392 Reduced 69.81%	49,036 $249,000
Q3 2018 Nov 14, 2018	SELL	$2.31 - $4.69 $104,735 - $212,644	-45,340 Reduced 21.82%	162,428 $517,000
Q2 2018 Aug 14, 2018	BUY	$4.04 - $5.13 $839,382 - $1.07 Million	207,768 New	207,768 $931,000
Q1 2018 May 15, 2018	SELL	$3.92 - $5.35 $85,118 - $116,169	-21,714 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.9 - $4.66 $84,684 - $101,187	21,714	21,714 $86,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $209M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account